Table 2.
Characteristics of ketamine-treated embryos (0.5 mg/ml) at stage 46
| Characteristic | Control | Ketamine (0.5 mg/ml) |
|---|---|---|
| Mortality | 17 (9.44 %) | 29 (16.11 %) |
| Heart defects | 3 (1.84 %) | 124* (82.12 %) |
| Enlarged | 2 (1.23 %) | 116* (76.82 %) |
| Undefined | 1 (0.61 %) | 8* (5.30 %) |
| Gut defects | 1 (0.61 %) | 7* (4.64 %) |
| Curved axis | 3 (1.84 %) | 30* (19.87 %) |
| Small head | 0 (0.00) | 1 (0.66 %) |
| Body length (mm) | 10.53 ± 0.20 | 8.86 ± 0.86* |
| Total embryos | 180 | 180 |
Note that one embryo can have various malformations. All malformations were individually counted and analyzed. The body length values are expressed as the means ± SD. *P < 0.05